GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » ROA %

Zhongyuan Union Cell & Gene Engineering (SHSE:600645) ROA % : 3.65% (As of Sep. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Zhongyuan Union Cell & Gene Engineering's annualized Net Income for the quarter that ended in Sep. 2024 was ¥193 Mil. Zhongyuan Union Cell & Gene Engineering's average Total Assets over the quarter that ended in Sep. 2024 was ¥5,295 Mil. Therefore, Zhongyuan Union Cell & Gene Engineering's annualized ROA % for the quarter that ended in Sep. 2024 was 3.65%.

The historical rank and industry rank for Zhongyuan Union Cell & Gene Engineering's ROA % or its related term are showing as below:

SHSE:600645' s ROA % Range Over the Past 10 Years
Min: -2.58   Med: 1.58   Max: 7.96
Current: 2.01

During the past 13 years, Zhongyuan Union Cell & Gene Engineering's highest ROA % was 7.96%. The lowest was -2.58%. And the median was 1.58%.

SHSE:600645's ROA % is ranked better than
85.7% of 1503 companies
in the Biotechnology industry
Industry Median: -35.24 vs SHSE:600645: 2.01

Zhongyuan Union Cell & Gene Engineering ROA % Historical Data

The historical data trend for Zhongyuan Union Cell & Gene Engineering's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongyuan Union Cell & Gene Engineering ROA % Chart

Zhongyuan Union Cell & Gene Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.07 -2.58 3.11 2.19 1.99

Zhongyuan Union Cell & Gene Engineering Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 -1.92 2.98 3.38 3.65

Competitive Comparison of Zhongyuan Union Cell & Gene Engineering's ROA %

For the Biotechnology subindustry, Zhongyuan Union Cell & Gene Engineering's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhongyuan Union Cell & Gene Engineering's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhongyuan Union Cell & Gene Engineering's ROA % distribution charts can be found below:

* The bar in red indicates where Zhongyuan Union Cell & Gene Engineering's ROA % falls into.



Zhongyuan Union Cell & Gene Engineering ROA % Calculation

Zhongyuan Union Cell & Gene Engineering's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=106.453/( (5284.619+5411.355)/ 2 )
=106.453/5347.987
=1.99 %

Zhongyuan Union Cell & Gene Engineering's annualized ROA % for the quarter that ended in Sep. 2024 is calculated as:

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=193.312/( (5309.097+5280.484)/ 2 )
=193.312/5294.7905
=3.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2024) net income data. ROA % is displayed in the 30-year financial page.


Zhongyuan Union Cell & Gene Engineering  (SHSE:600645) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=193.312/5294.7905
=(Net Income / Revenue)*(Revenue / Total Assets)
=(193.312 / 1614.468)*(1614.468 / 5294.7905)
=Net Margin %*Asset Turnover
=11.97 %*0.3049
=3.65 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Zhongyuan Union Cell & Gene Engineering ROA % Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhongyuan Union Cell & Gene Engineering Business Description

Traded in Other Exchanges
N/A
Address
45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
Executives
Li De Fu Director
Wang Xue Jun senior management
Wang Yong Director
Li Hai Bin Director
He Wei senior management
Li Qiang senior management
Wu Ming Yuan Director
Wang Hui Director
Huang Jia Xue senior management
Cao Hai Feng Director
Han Yue E Director
Liu Yong Jun senior management
Cui Jing Xue Supervisors
Yang Guang Xing senior management
Meng Zhi Hong senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines